Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 1
1997 1
2000 5
2001 4
2002 3
2003 7
2004 6
2005 12
2006 13
2007 15
2008 10
2009 10
2010 10
2011 6
2012 5
2013 6
2014 4
2015 3
2016 4
2017 3
2018 1
2019 2
2020 5
2021 2
2022 2
2023 6
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

132 results

Results by year

Filters applied: . Clear all
Page 1
Neoantigens in the immuno-oncology space.
Arlen PM. Arlen PM. Future Oncol. 2017 Oct;13(25):2209-2211. doi: 10.2217/fon-2017-0349. Epub 2017 Oct 4. Future Oncol. 2017. PMID: 28976211 Free article. No abstract available.
Rationale, discovery and clinical development of NEO-201.
Arlen PM, Morelli MP. Arlen PM, et al. Expert Opin Biol Ther. 2020 Feb;20(2):105-108. doi: 10.1080/14712598.2020.1696767. Epub 2019 Dec 24. Expert Opin Biol Ther. 2020. PMID: 31755317 No abstract available.
First-in-human phase 1 clinical trial of anti-core 1 O-glycans targeting monoclonal antibody NEO-201 in treatment-refractory solid tumors.
Cole CB, Morelli MP, Fantini M, Miettinen M, Fetsch P, Peer C, Figg WD, Yin T, Houston N, McCoy A, Lipkowitz S, Zimmer A, Lee JM, Pavelova M, Villanueva EN, Trewhitt K, Solarz BB, Fergusson M, Mavroukakis SA, Zaki A, Tsang KY, Arlen PM, Annunziata CM. Cole CB, et al. Among authors: arlen pm. J Exp Clin Cancer Res. 2023 Mar 29;42(1):76. doi: 10.1186/s13046-023-02649-6. J Exp Clin Cancer Res. 2023. PMID: 36991390 Free PMC article. Clinical Trial.
Abiraterone. Cougar Biotechnology.
Madan RA, Arlen PM. Madan RA, et al. Among authors: arlen pm. IDrugs. 2006 Jan;9(1):49-55. IDrugs. 2006. PMID: 16374734
Flutamide With or Without PROSTVAC in Non-metastatic Castration Resistant (M0) Prostate Cancer.
Madan RA, Bilusic M, Stein MN, Donahue RN, Arlen PM, Karzai F, Plimack E, Wong YN, Geynisman DM, Zibelman M, Mayer T, Strauss J, Chen G, Rauckhorst M, McMahon S, Couvillon A, Steinberg S, Figg WD, Dahut WL, Schlom J, Gulley JL. Madan RA, et al. Among authors: arlen pm. Oncologist. 2023 Jul 5;28(7):642-e561. doi: 10.1093/oncolo/oyad058. Oncologist. 2023. PMID: 37134294 Free PMC article. Clinical Trial.
Therapeutic vaccines for prostate cancer.
Tarassoff CP, Arlen PM, Gulley JL. Tarassoff CP, et al. Among authors: arlen pm. Oncologist. 2006 May;11(5):451-62. doi: 10.1634/theoncologist.11-5-451. Oncologist. 2006. PMID: 16720845 Free article. Review.
Costimulatory molecules as adjuvants for immunotherapy.
Hodge JW, Greiner JW, Tsang KY, Sabzevari H, Kudo-Saito C, Grosenbach DW, Gulley JL, Arlen PM, Marshall JL, Panicali D, Schlom J. Hodge JW, et al. Among authors: arlen pm. Front Biosci. 2006 Jan 1;11:788-803. doi: 10.2741/1837. Front Biosci. 2006. PMID: 16146771 Review.
132 results